Skip to content
Search

Latest Stories

GASTRO: Improving your patients’ gut health

Joshua Edwards shares five practical tips for pharmacy teams to support patients who have problems with their digestive system or gut health...

Gut microbiome is the combined genetic material (genomes) of the microorganisms residing in the gut. The term microbiota is used to describe the community of microorganisms themselves.


Lower microbiota diversity indicates a microbial imbalance within the gut, and is often found in people with autoimmune diseases, obesity and cardiometabolic conditions.

Studies have found that while there is a heritable component to gut microbiota, the role of environmental factors such as diet, drugs and anthropometric measures play a key role in one’s microbiota composition. Pharmacy teams are best placed to advise their patients on ways to improve their gut heath.

Popular media suggests the key to solving all health problems is to nurture the gut through drinking kombucha and avoiding gluten. But how true is this really? Ask your patients to consider implementing the following five tips, informed by scientific literature, into their diet and lifestyle, to improve the microbiota diversity.

Foods to avoid

First thing: avoid consuming high intensity sweeteners, like sucralose and aspartame. While sugar alternatives like sucralose, aspartame and saccharin are generally considered safe by regulatory bodies, studies have shown these sugar substitutes disrupt the balance and diversity of gut microbiota.

Researchers investigated the impact of non-nutritive sweeteners, including aspartame, saccharin, stevia, sucralose, alongside control groups, and found that all four of the tested sweeteners altered the bacteria in the gut and the molecules they secrete. Additionally, all four were seen to “distinctly impact” the oral microbiome of the person consuming them.

Such microbiome changes did not occur in the control groups, which suggest that the consumption of high intensity sweeteners may not be much better for our health than the consumption of sugar, which has been linked to health conditions like obesity and diabetes.

More recently, a study found that a new low-calorie sweetener promotes the growth of beneficial gut bacteria, which impacts overall health.

Drug interaction

Encourage your patients to have a conversation with you about medications that could be interacting with their gut microbiota. Diet is not the only factor that could impact on the health of gut microbiota, and medication has also been seen to play a key role in modulating the gut microbiota composition.

For example, antibiotics, which even when studying short-term courses, have been shown to decrease the taxonomic richness, diversity and reduce the colonized resistance from invading pathogens.

A large Dutch-Belgian population study found that drugs had the largest explanatory power on microbiota composition. Further studies have shown the major impact of commonly prescribed proton pump inhibitors on the microbial community, which may explain the higher rates of gastrointestinal infection seen in people taking these drugs. This may result in an alternative being chosen that is less likely to impact gut microbiota.

Probiotic supplements

Another good idea is to supplement with probiotics for various health benefits. Probiotics are live bacteria and yeasts that, if administered in a viable form and adequate amount, have beneficial effects on our overall health. Probiotics, like Bifidobacterium and Lactobacillus, can be added to yoghurts, taken as food supplements and even added to drugs.

The therapeutic effect of probiotic supplementation has been studied in a broad range of diseases. They can affect health independently of the gut microbiota through direct effects on the host, such as through immune modulation or the production of bioactive compounds.

Plant-based diet

There is merit in a shift towards a plant-based diet for better delivery of beneficial metabolites. Changes to the gut microbiota can occur within days of changing diet, and studies have shown a plant-based diet can increase the delivery of beneficial metabolites, produced by bacteria, like equol, whilst decreasing the production of harmful metabolites such as trimethylamine.

In the plasma metabolome of people eating a vegan diet, positive bacterial metabolites were more abundant while lipid and amino acid metabolites were less abundant, which may provide a health benefit compared to people eating a diet inclusive of meat.

If your patients eat a diet heavy in meat and dairy, you might want to ask them to consider reducing their consumption of these food types and incorporating more fresh fruit and vegetables, which are high in fibre to improve their gut health.

But they should incorporate less meat and more fibre gradually, because studies have shown that major increases in dietary fibre can temporarily reduce diversity, as the microbes that digest fibre become specifically enriched.

Individual sensitivities

Studies have found that glutenfree bread reduces the microbiota imbalance experienced by the people with gluten sensitivity or coeliac disease. However, studies have also shown that for people who do not have coeliac disease or an intolerance to gluten, avoiding gluten showed a reduced abundance of beneficial microbes and may lead to an increased risk of heart diseases, potentially due to a reduced consumption of key whole grains needed for healthy gut microbiota.

So before they restrict consumption of gluten, advise them to speak yourself or their GP about testing for an intolerance or sensitivity to the protein to be sure they are taking the right steps to improve their gut health.

(Joshua Edwards is a Pilltime pharmacist.)

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less